BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13087576)

  • 21. [Copper in hepatolenticular degeneration (H.L.D.)].
    Pardo R; Rubio HH
    Acta Gastroenterol Latinoam; 1971; 3(1):27-8. PubMed ID: 5135751
    [No Abstract]   [Full Text] [Related]  

  • 22. Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria.
    BEARN AG; KUNKEL HG
    J Clin Invest; 1954 Mar; 33(3):400-9. PubMed ID: 13143088
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathogenesis of hepatocerebral disease. II. Histochemical study of copper of liver and brain in Wilson's disease.
    OKINAKA S; YOSHIKAWA M; TOYODA M; MOZAI T; TOYOKURA Y; KAMEYAMA M
    AMA Arch Neurol Psychiatry; 1954 Nov; 72(5):573-8. PubMed ID: 13206477
    [No Abstract]   [Full Text] [Related]  

  • 24. NEW HYPOTHESES concerning Wilson's disease.
    Nutr Rev; 1958 Feb; 16(2):37-8. PubMed ID: 13517688
    [No Abstract]   [Full Text] [Related]  

  • 25. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; NeÄ­fakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 26. Copper metabolism in Wilson's disease, Laennec's cirrhosis and hemachromatosis: studies with radiocopper (Cu64).
    MAYTUM WJ; GOLDSTEIN NP; McGUCKIN WF; OWEN CA
    Proc Staff Meet Mayo Clin; 1961 Dec; 36():641-60. PubMed ID: 14471779
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolic studies in Wilson's disease using Cu64.
    BEARN AG; KUNKEL HG
    J Lab Clin Med; 1955 Apr; 45(4):623-31. PubMed ID: 14368026
    [No Abstract]   [Full Text] [Related]  

  • 28. An early defect in Wilson's disease.
    BARBEAU A; REILLY RW; MARVER H; KIRSNER JB
    Rev Can Biol; 1961 Apr; 20():25-35. PubMed ID: 13686754
    [No Abstract]   [Full Text] [Related]  

  • 29. Copper metabolism in Wilson's disease.
    WINTROBE MM; CARTWRIGHT GE; HODGES RE; GUBLER CJ; MAHONEY JP; DAUM K; BEAN WB
    Trans Assoc Am Physicians; 1954; 67():232-41. PubMed ID: 13216832
    [No Abstract]   [Full Text] [Related]  

  • 30. Copper transport and excretion in normal subjects and in patients with Laennec's cirrhosis and Wilson's disease: a study with CU64.
    JENSEN WN; KAMIN H
    J Lab Clin Med; 1957 Feb; 49(2):200-10. PubMed ID: 13398686
    [No Abstract]   [Full Text] [Related]  

  • 31. Copper metabolism in Wilson's Disease.
    Critz JB
    S D J Med; 1966 Sep; 19(9):59-65. PubMed ID: 5331489
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatocerebral degeneration. Its occurrence in the presence and in the absence of abnormal copper metabolism.
    Popoff N; Budzilovich G; Goodgold A; Feigin I
    Neurology; 1965 Oct; 15(10):919-30. PubMed ID: 5890884
    [No Abstract]   [Full Text] [Related]  

  • 33. [The behavior of serum copper and p-polyphenoloxydase activity in clinical and subclinical forms of hepatolenticular diseases].
    GASTAGER H; HORNYKIEWICZ O; TSCHABITSCHER H
    Wien Z Nervenheilkd Grenzgeb; 1954; 9(3):312-9. PubMed ID: 13205990
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic balances of copper in patients with hepatolenticular degeneration submitted to vegetarian and mixed diets.
    Canelas HM; de Jorge FB; Tognola WA
    J Neurol Neurosurg Psychiatry; 1967 Aug; 30(4):371-3. PubMed ID: 6055347
    [No Abstract]   [Full Text] [Related]  

  • 35. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.
    Lindquist RR
    Arch Pathol; 1969 Apr; 87(4):370-9. PubMed ID: 5766764
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the localization of copper in the brain in hepatolenticular degeneration].
    Levina GIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):990-3. PubMed ID: 4175278
    [No Abstract]   [Full Text] [Related]  

  • 38. Abnormal copper metabolism: another "non-Wilson's" case.
    Heckmann J; Saffer D
    Neurology; 1988 Sep; 38(9):1493-5. PubMed ID: 3274209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I; Van den Hamer CJ; Morell AG; Alpert S; Gregoriadis G; Scheinberg IH
    Gastroenterology; 1973 Jan; 64(1):99-105. PubMed ID: 4683859
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolism in Wilson's disease. Whole body counting of 64Cu].
    Terao T; Nakao K; Ogihara K; Mozai T; Nagai T
    Igaku To Seibutsugaku; 1967 Jun; 74(6):304-8. PubMed ID: 5624888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.